HALOZYME THERAPEUTICS INC (HALO)

US40637H1095 - Common Stock

39.12  +0.15 (+0.38%)

After market: 39.12 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
829.25M660.10M443.30M267.60M196.00M
Cost Of Goods
192.36M139.30M81.40M43.40M45.50M
Gross Profit
636.89M520.80M361.90M224.20M150.40M
Operating Expenses
296.82M231.40M86.00M79.90M218.10M
Research and Development
76.36M66.60M35.70M34.20M140.80M
Selling, General, and Administrative Expenses
149.18M121.60M50.30M45.70M77.30M
Operating Income
340.07M289.40M275.90M144.30M-67.60M
Interest Income/Expense
-2.44M-15.90M-6.40M-15.00M-4.60M
Other Income/Expense
13.20MN/AN/AN/AN/A
Non Recurring Items
-2.50M-24.60M-21.00MN/AN/A
Income Before Taxes
348.33M248.90M248.50M129.30M-72.30M
Income Tax
66.73M46.80M-154.20M200.00K0.00
Net Income
281.59M202.10M402.70M129.10M-72.20M
EBITDA
424.93M339.00M278.90M147.60M-63.50M
 
Per Share Data
EPS Diluted Total Ops
2.101.442.740.91-0.50
Non GAAP EPS
2.782.221.920.90-0.50
 
Statistics
Gross Profit Margin
76.80%78.90%81.64%83.78%76.73%
Profit Margin
33.96%30.62%90.84%48.24%-36.84%
Operating Profit Margin
41.01%43.84%62.24%53.92%-34.49%

All data in USD

Charts